The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-1.3% to $29.80
Predicted High$30.50at 5 months
Predicted Low$25.80at 2 months
Max Drawdown (predicted)-14.5%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Sep 19, 2026 1:04 pm
Neutral
AMSC trends range-bound to
$29.80
(-1.3% from $30.19)
by Mar 2027.
dip-then-recover
ThesisAMSC sits between a bullish composite fair value near $41 and a bearish sentiment/regime backdrop with beta over 3, so the near-term path likely fades on risk-off pressure before value gravity partially reasserts. No earnings catalyst inside the window means drift and macro beta dominate. Endpoint lands modestly below current, close to the deterministic baseline but with a visible dip-and-recover shape.
Invalidated ifA sustained close above $36 on volume, or a breakdown below $22, would falsify this mean-reverting path.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $30.19 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Sep 19, 2026
—
$30.19at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Oct 3, 2026
$26.41–$33.97typical range · internal point $29.10
What actually happened:
closed $30.01
on Oct 2, 2026 = -0.6% vs the call
(predicted -3.6%)
· direction HIT
(called flat, was flat)
· off by 3.0 pp
· accuracy 9/10
· typical range ±12.5%:
inside the band
· S&P +0.9%
over the same window — lagged it
1 month
Oct 19, 2026
$24.71–$35.67typical range · internal point $27.40
—
±18.1%
5/10
Sentiment overhang and no catalyst drag continues
2 months
Nov 19, 2026
$25.80
—
-14.5%
4/10
Beta amplifies neutral regime chop into November
3 months
Dec 19, 2026
$27.20
—
-9.9%
4/10
Value buyers emerge near bear scenario zone
4 months
Jan 19, 2027
$29.00
—
-3.9%
4/10
January rebalancing and earnings anticipation lift
5 months
Feb 19, 2027
$30.50
—
+1.0%
4/10
Q4 print potential draws fair-value gravity higher
6 months
Mar 19, 2027
$29.80
—
-1.3%
3/10
Settles near baseline as macro uncertainty persists
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$29.22
(-3.2%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.
Weaknesses
No weaknesses recorded for this run.
All inputs present, no fallbacks used — nothing to flag.
Equation Inputs
Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.
Value anchors (from deep analysis)
Price at call
$30.19
Composite fair value
$41.19
Signal-adjusted fair value
$43.59
DCF fair value
$5.51
Anchored-PE fair value
$150.13
Buy-below (value lens)
$20.00
Value net score
-57
Value confidence
6 / 10
Quality net score
+30
Memo confidence
7 / 10
Deserved value (base)
—
Quality tilt
—
Deserved value (used)
—
Coherence (value × quality)
—
Price behaviour (trailing — shapes the realism line)